Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Immunology Pubmed

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Clinical Immunology , Volume 98 (2): -262 – Mar 29, 2001

The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.

Clinical Immunology , Volume 98 (2): -262 – Mar 29, 2001

Loading next page...
 
/lp/pubmed/the-phosphodiesterase-inhibitors-pentoxifylline-and-rolipram-suppress-xSarAPfLFx

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1521-6616
DOI
10.1006/clim.2000.4964
pmid
11161985

Abstract

Journal

Clinical ImmunologyPubmed

Published: Mar 29, 2001

There are no references for this article.